Scarica l'app Stockscreener
14.36
6.45%
-0.99
Dopo l'orario di chiusura:
18.40
4.04
+28.13%
Rapport Therapeutics Inc Borsa (RAPP) Ultime notizie
Short interest data insights for Rapport Therapeutics Inc.Buy Signal & Verified Swing Trading Watchlists - Newser
What moving averages say about Rapport Therapeutics Inc.2025 Market Overview & Trade Opportunity Analysis Reports - Newser
Short Interest Drops in Rapport Therapeutics Inc. After RallyJuly 2025 Reactions & Fast Momentum Stock Entry Tips - beatles.ru
Ranking Rapport Therapeutics Inc. among high performing stocks via toolsBreakout Watch & Low Drawdown Momentum Ideas - Newser
Rapport Therapeutics to report phase 2a trial results for epilepsy drug - Investing.com Canada
Will Rapport Therapeutics Inc. benefit from AI trendsJuly 2025 Breakouts & High Accuracy Investment Signals - خودرو بانک
Can Rapport Therapeutics Inc. continue delivering strong returnsJuly 2025 Review & Daily Stock Momentum Reports - خودرو بانک
Rapport Therapeutics to report phase 2a trial results for epilepsy drug By Investing.com - Investing.com South Africa
Rapport Therapeutics To Report Epilepsy Trial Results On MondayWill The Stock Surge Or Tumble? - Nasdaq
Rapport Therapeutics' RAP-219: A Precision Medicine Play with High Stakes in September - AInvest
Earnings visualization tools for Rapport Therapeutics Inc.2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
What hedge funds are buying Rapport Therapeutics Inc.Weekly Earnings Recap & Safe Entry Momentum Stock Tips - خودرو بانک
Rapport Therapeutics soars 23% on release of phase 2 data for seizure asset - Seeking Alpha
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025 - The Manila Times
Rapport Therapeutics to Host Conference Call for Phase 2a Trial Topline Results of RAP-219 for Drug-Resistant Focal Onset Seizures - Quiver Quantitative
Rapport Therapeutics to Announce Topline Results for - GlobeNewswire
Key Epilepsy Drug Trial Results Coming Monday: Rapport's RAP-219 Phase 2a Data Could Impact Treatment - Stock Titan
Machine Learning Models Forecast Rapport Therapeutics Inc. UptickQuarterly Market Review & Risk Adjusted Swing Trade Ideas - beatles.ru
What is Rapport Therapeutics Inc. s 5 year growth outlookJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - خودرو بانک
Building trade automation scripts for Rapport Therapeutics Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Evaluating Rapport Therapeutics Inc. with trendline analysisWeekly Profit Report & Verified Swing Trading Watchlist - Newser
Best data tools to analyze Rapport Therapeutics Inc. stockMarket Rally & High Conviction Buy Zone Alerts - Newser
Using RSI to spot recovery in Rapport Therapeutics Inc.2025 Sector Review & Accurate Entry/Exit Alerts - Newser
Measuring Rapport Therapeutics Inc.’s beta against major indicesJuly 2025 Reactions & Momentum Based Trading Ideas - Newser
Head-To-Head Analysis: Biofrontera (NASDAQ:BFRI) and Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Will Rapport Therapeutics Inc. outperform the marketWeekly Trend Summary & High Return Trade Opportunity Guides - Newser
Real time scanner hits for Rapport Therapeutics Inc. explainedQuarterly Trade Review & Risk Adjusted Buy/Sell Alerts - Newser
What data driven models say about Rapport Therapeutics Inc.’s futureMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
Rapport Therapeutics Inc. stock prediction for this weekMarket Sentiment Summary & Safe Entry Zone Tips - Newser
Analyzing Rapport Therapeutics Inc. with multi timeframe chartsMarket Growth Review & Detailed Earnings Play Strategies - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is Rapport Therapeutics Inc. stock poised for growthJuly 2025 Retail & Weekly High Return Stock Opportunities - Newser
Real time breakdown of Rapport Therapeutics Inc. stock performanceMarket Trend Review & Growth Focused Stock Reports - Newser
Is this a good reentry point in Rapport Therapeutics Inc.July 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Analyzing drawdowns of Rapport Therapeutics Inc. with statistical toolsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Should you wait for a breakout in Rapport Therapeutics Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Is Rapport Therapeutics Inc. stock a value trap2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - khodrobank.com
How to monitor Rapport Therapeutics Inc. with trend dashboardsPortfolio Gains Report & Accurate Buy Signal Notifications - Newser
What’s the fair value of Rapport Therapeutics Inc. stockEarnings Overview Report & Weekly Top Gainers Alerts - خودرو بانک
Is Rapport Therapeutics Inc. reversing from oversold territory2025 Investor Takeaways & Weekly Top Gainers Alerts - Newser
Why Rapport Therapeutics Inc. is moving todayMarket Performance Report & Growth Focused Investment Plans - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
Analyst Calls: Is now the right time to enter Rapport Therapeutics Inc.Earnings Trend Report & AI Powered Trade Plan Recommendations - خودرو بانک
Does Rapport Therapeutics Inc. meet Warren Buffett’s criteriaQuarterly Market Summary & Free Safe Entry Trade Signal Reports - خودرو بانک
Fed Watch: Can Rapport Therapeutics Inc. withstand a market correction2025 Technical Patterns & Growth Focused Entry Reports - خودرو بانک
Bank Watch: How does Rapport Therapeutics Inc. compare to its peersTrade Ideas & Technical Buy Zone Confirmations - خودرو بانک
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):